SPOTLIGHT -
Irvine, CA-Visiogen Inc. says it has received FDA approval to expand its phase III U.S. clinical trial for its dual-optic accommodating IOL (Synchrony).
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI
(EyePod) From idea to impact: Navigating ophthalmic innovation
Orbis, FundamentalVR team up to target training
EyePod: Modifier Gene Therapy: What is it?
ARVO flying high in Seattle
Intracortical Visual Prosthesis achieves 2 years of successful testing